Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
Fixed Capital/Sales

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   Fixed Capital/Sales(x) 0.440.420.360.29

What is the latest Fixed Capital/Sales ratio of CORONA REMEDIES ?

The latest Fixed Capital/Sales ratio of CORONA REMEDIES is 0.44 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.44
Mar20250.42
Mar20240.36
Mar20230.29

How is Fixed Capital/Sales of CORONA REMEDIES Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.44
4.76
Mar2025 0.42
16.67
Mar2024 0.36
24.14
Mar2023 0.29 -

Other Financial Ratios of CORONA REMEDIES


Compare Fixed Capital/Sales ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,384.7 Cr -0.8% -8% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -0.8% -5.1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -3.2% -1.4% 53.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -1.6% -6% 32.1% Stock Analytics
CIPLA ₹107,447.0 Cr 0% -3.6% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 3.1% 8.7% -1.5% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.8%

-8%

NA
SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses